Literature DB >> 10902537

Secretion of 13C-labelled oligosaccharides into human milk and infant's urine after an oral [13C]galactose load.

S Obermeier1, S Rudloff, G Pohlentz, M J Lentze, C Kunz.   

Abstract

Human milk oligosaccharides seem to play an important role in the infant's defense against bacterial and viral infections of the gastrointestinal and the urogenital tract. In this study, we investigated the influence of dietary carbohydrates on the biosynthesis of lactose and oligosaccharides in the human mammary gland and their renal excretion by the human milk-fed infant. For this purpose, a lactating woman was given 27 g galactose (Gal) containing 2 g [13C] Gal (1-13C/99%) immediately after breakfast. In the following 36 h, milk (5-10 ml) was collected before each nursing. Infant's urine was collected over a period of 24 h. 13C-enrichment was measured in total milk, milk fat and protein, in the carbohydrate fraction as well as in urine by isotope ratio mass spectrometry (IRMS). Milk carbohydrates and deproteinized urine samples were fractionated by Sephadex G25 gel filtration and further analyzed by IRMS, high performance thin layer chromatography and and high pH anion exchange chromatography with pulsed amperometric detection (HPAEC-PAD). IRMS revealed that in milk a maximal delta 13CPDB was reached within 8 h after Gal intake which then rapidly declined in the following 8 h. The cumulative 13C-elimination over this first peak was 6.9% of the oral 13C-dose. The highest 13C-enrichment was detectable in the carbohydrate fraction, mainly in lactose and neutral oligosaccharides. Compared to the enrichment of human milk, the delta 13CPDB of infant's urine was delayed. In urine, the highest amount of 13C was found in the Sephadex G25 fractions which mainly contained lactose, fucosyl-lactose, lacto-N-tetraose (LNT), fucosyl-LNT and difucosyl-LNT. For further characterization, individual components were separated by HPAEC-PAD and subsequently analyzed by fast atom bombardment mass spectrometry and IRMS. The data show, that orally applied Gal is incorporated in milk, especially in lactose and neutral oligosaccharides. Obviously, some of these components were absorbed by the infant and then excreted with urine. There, oligosaccharides may serve as analogous receptors for bacterial or viral adhesion molecules, and, hence, may prevent urogenital infections in breastfed infants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10902537     DOI: 10.1080/10256019908234084

Source DB:  PubMed          Journal:  Isotopes Environ Health Stud        ISSN: 1025-6016            Impact factor:   1.675


  16 in total

Review 1.  Overcoming the limited availability of human milk oligosaccharides: challenges and opportunities for research and application.

Authors:  Lars Bode; Nikhat Contractor; Daniela Barile; Nicola Pohl; Anthony R Prudden; Geert-Jan Boons; Yong-Su Jin; Stefan Jennewein
Journal:  Nutr Rev       Date:  2016-10       Impact factor: 7.110

Review 2.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

Review 3.  Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides.

Authors:  David A Sela; David A Mills
Journal:  Trends Microbiol       Date:  2010-04-19       Impact factor: 17.079

Review 4.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

5.  Detection of milk oligosaccharides in plasma of infants.

Authors:  L Renee Ruhaak; Carol Stroble; Mark A Underwood; Carlito B Lebrilla
Journal:  Anal Bioanal Chem       Date:  2014-07-25       Impact factor: 4.142

6.  A quantitative and comprehensive method to analyze human milk oligosaccharide structures in the urine and feces of infants.

Authors:  Maria Lorna A De Leoz; Shuai Wu; John S Strum; Milady R Niñonuevo; Stephanie C Gaerlan; Majid Mirmiran; J Bruce German; David A Mills; Carlito B Lebrilla; Mark A Underwood
Journal:  Anal Bioanal Chem       Date:  2013-03-07       Impact factor: 4.142

Review 7.  Structure-function relationships of human milk oligosaccharides.

Authors:  Lars Bode; Evelyn Jantscher-Krenn
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 8.  Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro.

Authors:  Mostafa Asadpoor; Casper Peeters; Paul A J Henricks; Soheil Varasteh; Roland J Pieters; Gert Folkerts; Saskia Braber
Journal:  Nutrients       Date:  2020-06-16       Impact factor: 5.717

9.  Non-Digestible Oligosaccharides Can Suppress Basophil Degranulation in Whole Blood of Peanut-Allergic Patients.

Authors:  Simone M Hayen; Constance F den Hartog Jager; André C Knulst; Edward F Knol; Johan Garssen; Linette E M Willemsen; Henny G Otten
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

10.  Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; John Kearney; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.